What Europe could lose: a regulatory system in the spotlight
This article was originally published in RAJ Devices
What is wrong with the EU's medical technology regulatory system? Recent comments and actions from certain key bodies have given the impression that it's open season on the directives and the "new approach" that underpins them. But international device expert Trevor Lewis urges caution and a measured approach. Making the system work is the responsibility of all stakeholders, he tells Ashley Yeo.
You may also be interested in...
The MHRA has been working all hours to ensure the standalone medtech UKCA mark works operationally and procedurally in the UK as of 1 January 2021.
Siemens Healthineers' product mix of diagnostics and imaging products meant it was in the middle of a very dynamic situation when COVID-19 struck.
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.